Terms: = Ovarian cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3
199 results:
1. [Gonadoblastoma: Clinicopathological study and literature review of 3 cases].
Bao ML; Li X; Chen G; Li H; Chen W; Li HX
Zhonghua Nan Ke Xue; 2023 Jul; 29(7):634-638. PubMed ID: 38619412
[TBL] [Abstract] [Full Text] [Related]
2. Correlation analysis of cancer stem cell marker CD133 and human endogenous retrovirus (HERV)-K env in SKOV3 ovarian cancer cells.
Kim DY; Kim H; Ko EJ; Koh SB; Kim H; Lee JY; Lee CM; Eo WK; Kim KH; Cha HJ
Genes Genomics; 2024 Apr; 46(4):511-518. PubMed ID: 38457096
[TBL] [Abstract] [Full Text] [Related]
3. Curcumin modulates cell type-specific miRNA networks to induce cytotoxicity in ovarian cancer cells.
Ravindran F; Mhatre A; Koroth J; Narayan S; Choudhary B
Life Sci; 2023 Dec; 334():122224. PubMed ID: 38084671
[TBL] [Abstract] [Full Text] [Related]
4. Scoulerine promotes cytotoxicity and attenuates stemness in ovarian cancer by targeting PI3K/AKT/mTOR axis.
Wang F; Zhang Y; Pang R; Shi S; Wang R
Acta Pharm; 2023 Sep; 73(3):475-488. PubMed ID: 37708956
[TBL] [Abstract] [Full Text] [Related]
5. cancer Stem Cell Markers-Clinical Relevance and Prognostic Value in High-Grade Serous ovarian cancer (HGSOC) Based on The cancer Genome Atlas Analysis.
Iżycka N; Zaborowski MP; Ciecierski Ł; Jaz K; Szubert S; Miedziarek C; Rezler M; Piątek-Bajan K; Synakiewicz A; Jankowska A; Figlerowicz M; Sterzyńska K; Nowak-Markwitz E
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628927
[TBL] [Abstract] [Full Text] [Related]
6. HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis.
Di Agostino S; Canu V; Donzelli S; Pulito C; Sacconi A; Ganci F; Valenti F; Goeman F; Scalera S; Rollo F; Bagnato A; Diodoro MG; Vizza E; Carosi M; Rufini B; Federici O; Giofrè M; Carboni F; Muti P; Ciliberto G; Strano S; Valle M; Blandino G
Cell Death Dis; 2023 Aug; 14(8):535. PubMed ID: 37598177
[TBL] [Abstract] [Full Text] [Related]
7. Regulation of self-renewal in ovarian cancer stem cells by fructose via chaperone-mediated autophagy.
Sohn EJ; Kim JH; Oh SO; Kim JY
Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166723. PubMed ID: 37087023
[TBL] [Abstract] [Full Text] [Related]
8. Low-dose BPA and its substitute BPS promote ovarian cancer cell stemness via a non-canonical PINK1/p53 mitophagic signaling.
Yuan X; Chen K; Zheng F; Xu S; Li Y; Wang Y; Ni H; Wang F; Cui Z; Qin Y; Xia D; Wu Y
J Hazard Mater; 2023 Jun; 452():131288. PubMed ID: 36989771
[TBL] [Abstract] [Full Text] [Related]
9. Undetectable anti-Mullerian hormone and inhibin B do not preclude the presence of germ cell tumours in 45,X/46,XY or 46,XY gonadal dysgenesis.
Hannema SE; Wolffenbuttel KP; van Bever Y; Brüggenwirth HT; van den Berg SAA; Hersmus R; Oosterhuis JW; Looijenga LHJ
Clin Endocrinol (Oxf); 2023 Jul; 99(1):58-63. PubMed ID: 36905105
[TBL] [Abstract] [Full Text] [Related]
10. Anti-ovarian cancer actions and pharmacological targets of plumbagin.
Liang K; Pan X; Chen Y; Huang S
Naunyn Schmiedebergs Arch Pharmacol; 2023 Jun; 396(6):1205-1210. PubMed ID: 36692828
[TBL] [Abstract] [Full Text] [Related]
11. Adult granulosa cell tumour of the testis: an uncommon tumour.
Wahlstedt ER; Allison DB; Bell JR
BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36572453
[TBL] [Abstract] [Full Text] [Related]
12. TAZ Regulates the Cisplatin Resistance of Epithelial ovarian cancer Cells via the ANGPTL4/SOX2 Axis.
Li C; Wang Q; Luo Y; Xiang J
Anal Cell Pathol (Amst); 2022; 2022():5632164. PubMed ID: 36247876
[TBL] [Abstract] [Full Text] [Related]
13. NANOG regulates epithelial-mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells.
Yun H; Han GH; Kim J; Chung JY; Kim JH; Cho H
J Cell Mol Med; 2022 Oct; 26(20):5277-5291. PubMed ID: 36114703
[TBL] [Abstract] [Full Text] [Related]
14. An experimental model for ovarian cancer: propagation of ovarian cancer initiating cells and generation of ovarian cancer organoids.
Chen YA; Lu CY; Cheng WF; Kuo KT; Yu CW; Ho HN; Chen HF; Pan SH
BMC Cancer; 2022 Sep; 22(1):967. PubMed ID: 36085021
[TBL] [Abstract] [Full Text] [Related]
15. Dysregulated FOXM1 signaling in the regulation of cancer stem cells.
Sher G; Masoodi T; Patil K; Akhtar S; Kuttikrishnan S; Ahmad A; Uddin S
Semin Cancer Biol; 2022 Nov; 86(Pt 3):107-121. PubMed ID: 35931301
[TBL] [Abstract] [Full Text] [Related]
16. Therapeutic Targeting of ovarian cancer Stem Cells Using Estrogen Receptor Beta Agonist.
He Y; Alejo S; Venkata PP; Johnson JD; Loeffel I; Pratap UP; Zou Y; Lai Z; Tekmal RR; Kost ER; Sareddy GR
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806169
[TBL] [Abstract] [Full Text] [Related]
17. PIK3R3, a regulatory subunit of PI3K, modulates ovarian cancer stem cells and ovarian cancer development and progression by integrative analysis.
Sohn EJ
BMC Cancer; 2022 Jun; 22(1):708. PubMed ID: 35761259
[TBL] [Abstract] [Full Text] [Related]
18. Sex chromosome DSD individuals with mosaic 45,X0 and aberrant Y chromosomes in 46,XY cells: distinct gender phenotypes and germ cell tumour risks
Vogt PH; Besikoglu B; Bettendorf M; Frank-Herrmann P; Zimmer J; Bender U; Knauer-Fischer S; Choukair D; Sinn P; Doerr HG; Woelfle J; Heidemann PH; Lau YC; Strowitzki T
Syst Biol Reprod Med; 2022 Aug; 68(4):247-257. PubMed ID: 35481403
[TBL] [Abstract] [Full Text] [Related]
19. Identification of microRNA expression profiles of CD44
Wang L; Zhi X; Lu Y; Cong Y; Fu Z; Cao J; Xu S; Lv J; Ruan H
Arch Gynecol Obstet; 2022 Aug; 306(2):461-472. PubMed ID: 35076757
[TBL] [Abstract] [Full Text] [Related]
20. Renal cell tumor with sex-cord/gonadoblastoma-like features: analysis of 6 cases.
Wang G; Amin MB; Grossmann P; Ptáková N; Hayes M; Hartmann A; Agaimy A; Lopez JI; Michal M; Hes O
Virchows Arch; 2022 Feb; 480(2):349-358. PubMed ID: 34775513
[TBL] [Abstract] [Full Text] [Related]
[Next]
